Diklofenak/omeprazol PharmaSwiss 75 mg/20 mg trde kapsule s prirejenim sproščanjem Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

diklofenak/omeprazol pharmaswiss 75 mg/20 mg trde kapsule s prirejenim sproščanjem

pharmaswiss Česká republika s.r.o. - omeprazol; natrijev diklofenakat - kapsula s prirejenim sproščanjem, trda - omeprazol 20 mg / 1 kapsula  natrijev diklofenakat75 mg / 1 kapsula; natrijev diklofenakat 75 mg / 1 kapsula - diklofenak, kombinacije

Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Evropska unija - slovenščina - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - klopidogrel hidroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotična sredstva - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Mestinon 60 mg obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mestinon 60 mg obložene tablete

meda pharma gmbh & co. kg - piridostigmin - obložena tableta - piridostigmin 60 mg / 1 tableta - piridostigmin

Aldactone 25 mg obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aldactone 25 mg obložene tablete

riemser pharma gmbh - spironolakton - obložena tableta - spironolakton 25 mg / 1 tableta - spironolakton

Aldactone 50 mg obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aldactone 50 mg obložene tablete

riemser pharma gmbh - spironolakton - obložena tableta - spironolakton 50 mg / 1 tableta - spironolakton

Aldactone 100 mg trde kapsule Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aldactone 100 mg trde kapsule

riemser pharma gmbh - spironolakton - kapsula, trda - spironolakton 100 mg / 1 kapsula - spironolakton

Lodotra 5 mg tablete s prirejenim sproščanjem Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lodotra 5 mg tablete s prirejenim sproščanjem

mundipharma gmbh - prednizon - tableta s prirejenim sproščanjem - prednizon 5 mg / 1 tableta - prednizon

Lodotra 2 mg tablete s prirejenim sproščanjem Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lodotra 2 mg tablete s prirejenim sproščanjem

mundipharma gmbh - prednizon - tableta s prirejenim sproščanjem - prednizon 2 mg / 1 tableta - prednizon

Targinact 15 mg/7,5 mg tablete s podaljšanim sproščanjem Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

targinact 15 mg/7,5 mg tablete s podaljšanim sproščanjem

mundipharma gmbh - nalokson, oksikodon - tableta s podaljšanim sproščanjem - nalokson 4,5 mg / 1 tableta; oksikodon 9 mg / 1 tableta - oksikodon in nalokson

Targinact 15 mg/7,5 mg tablete s podaljšanim sproščanjem Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

targinact 15 mg/7,5 mg tablete s podaljšanim sproščanjem

mundipharma gmbh - nalokson, oksikodon - tableta s podaljšanim sproščanjem - nalokson 4,5 mg / 1 tableta; oksikodon 9 mg / 1 tableta - oksikodon in nalokson